32 Stocks Moving In Monday’s Mid-Day Session
Gainers
Nuvectis Pharma, Inc. (NASDAQ: NVCT) jumped 191.2% to $9.47. The company, on Friday, priced its IPO at $5 per share.
Mid-Day Market Update: US Stocks Down; Nasdaq Falls 50 Points
Midway through trading Monday, the Dow traded down 0.10% to 35,053.40 while the NASDAQ fell 0.36% to 14,046.74. The S&P also fell, dropping, 0.26% to 4,488.93.
Also check out this: Executives Sell Over $45M Of 5 Stocks
‘A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers’ – ClinicalTrials.gov
https://clinicaltrials.gov/ct2/show/NCT05226507
This Week’s Scheduled IPOs
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.